Mold Exposure Symptoms: What Holds Up When You Already Hurt

She is forty-six. Four months of disciplined work bought back about forty percent of her life, and then the progress quit. Her stool inflammation marker stays mildly elevated. She feels well on vacation and unwell in her own kitchen, and she has said so to three physicians.

All three wrote down stress. None asked about the basement that flooded in 2019 and was left to dry on its own. That gap is where most searches for mold exposure symptoms begin, and it is why an industry now sells the answer her doctors would not discuss.

I am Dr. Gurpreet Singh Padda, MD, MBA, MHP, and I wrote The Angry Gut with Ami Michelle Grimes. The video Mold Illness: Fix the Basement, Skip the Panel grades the evidence out loud. What follows answers the question a pain practice faces: what a wet building can do to a body that already hurts, and what it cannot.

Picture the gut as the first brain, with the vagus carrying its reports up to the second brain behind your eyes. Years of low-grade metaflammation below arrive above as fatigue, flattened mood and pain that stops tracking with tissue damage. The intestinal barrier is the wall of the first brain, and every argument about mold eventually runs through it.

What mold toxins are proven to do, and to whom

Start where the ground is solid. Aflatoxin is a mold toxin classified as carcinogenic to humans. It causes liver cancer, and in high-exposure regions up to 50% of liver cancers carry the same TP53 mutation. Modeled worldwide, it may account for 4.6-28.2% of liver cancer, or 25,200 to 155,000 cases a year.

Name the population, because it decides everything after it. That burden sits in sub-Saharan Africa, Southeast Asia and China, where uncontrolled aflatoxin in food meets high hepatitis B prevalence. When investigators tested repeated samples from fifty American women through pregnancy, carcinogenic aflatoxins were not detected in any sample.

Other compounds were everywhere. Deoxynivalenol turned up in 99% of their urines at a median of 23 ng/mL, ochratoxin A in 46% of blood samples and enniatin B in 97%. These toxins ride in the food supply, so nearly everyone carries them. Presence is a census, and a census never says what anyone in the room is doing.

Route matters too. American medical toxicology names diet as the dominant source of exposure and models the inhaled dose inside a moldy building at orders of magnitude below harmful levels. The one inhalation illness toxicologists accept, the silo unloader’s syndrome, needs far larger exposures and resolves within hours to days.

Mold exposure symptoms: damp buildings, airways, and the organ the guidelines leave out

The 2004 American synthesis found sufficient evidence tying damp indoor spaces to some upper respiratory symptoms, and toxicologists still endorse it. A 2024 European guideline grades respiratory disease sufficient, atopic eczema limited or suspected, and gastrointestinal effects inadequate or insufficient.

I will not bury that last tier. The organ The Angry Gut is about sits in the weakest category of the best consensus document in the field, and a page that hid it would not deserve belief on anything else.

Outside the chest, the measured signal is old and crude. Across 597 households, adults in damp, moldy dwellings reported more symptoms, nausea and vomiting among them, rising with the severity of the damp and holding after adjustment for income, smoking, unemployment and overcrowding. The children in those same houses showed a different excess: respiratory symptoms, headaches and fever, not gut complaints.

Sorted by the strength of the evidence behind them, the mold exposure symptoms in the literature look like this:

• Well supported: upper respiratory symptoms and wheezing, plus the defined immune diseases: asthma, allergic rhinitis, sinusitis and hypersensitivity pneumonitis.
• Limited or suspected: atopic eczema.
• Crude household signals: nausea and vomiting in adults; respiratory symptoms, headaches and fever in children.
• Inadequate or insufficient: gastrointestinal effects.

Why the word in the chart is stress

I used that word myself, years ago, in charts belonging to women who sound exactly like her. I had no test to offer and a waiting room to clear, and stress is the one word a chart always accepts. What changed my mind was not a paper. It was watching people improve away from a building and decline again inside it.

Three drivers stack under her stall, and only two are biological. The intestinal barrier is the first: mycotoxins degrade its physical, mucus, immune and microbial compartments, though that work rests on cell, tissue and animal models. The immune system is the second, where asthma, allergic rhinitis, sinusitis and hypersensitivity pneumonitis are well defined and the newer mold illnesses remain largely unproved. An activated immune system is not a confused one.

The third driver is money, and none of it is hers. Drying a foundation properly is expensive, ignoring it is free, and the person who signs for the work is rarely the one sleeping above it. Then the trials screen her out, because entry criteria remove the patient with four medications, broken sleep and a wet basement. Mechanism is not a weak substitute for a trial. It is what remains once the trial design discards the person in front of you.

The panel that cannot come back positive

There is no FDA-approved test for mycotoxins in human urine. Traces ride in everyday groceries, which puts them in the urine of perfectly well people, and the laboratory rules these panels are sold under never ask whether the assay measures what it claims.

One federal case shows the cost. Ochratoxin came back at 2.8 parts per billion where the laboratory called 2.0 positive, and trichothecenes at 0.4 where its line sat at 0.2. Each result sat over its own threshold. Investigators then tore out drywall, carpet and ceiling tile and found no water damage and no significant fungal growth. A result with no validated threshold cannot be positive. It can only sit above a number somebody chose.

The framework’s evidence, and the one outside attempt to repeat it

The protocol sold beside those panels rests on a small base. A 2024 review found it described in 11 of the 13 articles it identified, with little publication from any other group, and the randomized evidence is two cholestyramine trials with 8 and 13 subjects. In the primary one, seven people on the drug improved, the six on placebo did not until they crossed over, and all relapsed when sent back into the buildings without it.

The single independent replication half worked. Comparing 28 exposed people with 30 controls, the handheld contrast chart the protocol sells could not separate the groups, but digital contrast testing reached 100% sensitivity at 60-80% specificity. The exposed group also scored 45.50 ± 13.0 on a neurotoxicity questionnaire against 22.00 ± 7.7. No exposure biomarker was measured, so circular reasoning is hard to rule out. Not nothing, and not established.

What I do when a recovery stalls in a wet house

The intervention with the cleanest human outcome data is a contractor. Pooled in a Cochrane review, repairing damp and moldy houses cut wheezing in adults at an odds ratio of 0.64 and rhinitis at 0.57, on moderate-quality evidence. Children showed no difference in asthma days. Even the occupational medicine paper that rejects the diagnosis says indoor mold growth should not be tolerated.

So her basement gets remediated properly, and she lives elsewhere during the two weeks of work. We do not order the panel, because a positive would not change the plan and a negative would not settle her mind. Her observation becomes the instrument: better away, worse at home, recorded as dates rather than moods. If she improves out of the building and slides back on return, that is a result, one patient, and I will call it that.

Sleep, food and movement all have more room to work once the exposure is gone, and sleep and chronic pain feed each other in both directions. None of this is a reason to start, stop or change a medication; take that to the physician who prescribed it. The acid blocker is not the villain in her story. It is the right drug for an ulcer and the wrong answer to a stall.

Every study behind the argument, graded, sits in the chapter Deep Dive: each number, the population it came from, and what it does not show. Measuring before treating is the rule. Here the measurement is her, at two addresses, and skipping it means years more of hearing that her sharpest observation about her own body was anxiety.

Frequently asked questions

Can mold exposure cause chronic pain?

No trial has tested that in people living with chronic pain. The consensus documents support respiratory effects of damp buildings and place gastrointestinal effects in the weakest tier. An adult housing survey did find more nausea and vomiting in damp homes, which is suggestive and nothing more. Treat it as a mechanism worth acting on, not a diagnosis. Why a scan so often fails to match the pain is a separate question worth reading.

Is a urine mycotoxin test worth paying for?

It cannot do what buyers expect. No urine assay is FDA-approved, the compounds are present in healthy people, and no population distribution comes with the result. In one detailed federal case, two compounds cleared their cutoffs and the building proved sound. Ask what a positive would change before ordering one. What a binder like cholestyramine actually grabs in the gut is a different story.

Why do I feel better on vacation and worse at home?

That pattern is the most useful information you own, so record it as dates rather than impressions. Buildings are not the only explanation, since pollen does the same thing on a seasonal calendar. Bring the log to your physician and note what else differs between the two places. How chronic noise at home can hold a nervous system in pain is one of those differences.

Does repairing a damp building actually help?

For adult airways, yes, and it is the strongest human result on this subject. Pooled trials of repairing damp, moldy houses reduced wheezing and rhinitis in adults. Asthma days in children did not move, and no included trial measured a gut outcome. Repair it anyway, because even the physicians who reject mold illness say indoor mold should not be tolerated. Drainage from above is the next thing to rule out.

My labs are normal and I still hurt. What now?

Normal labs rule out a short list and prove nothing about sensitization. The useful next move is changing one exposure at a time and watching what the body does, which is slower than a panel and far more informative. Three physicians writing stress is not three findings. Why normal results are expected in a fibromyalgia evaluation explains the rest.

Sources

1. Hurraß, J., Heinzow, B., Walser-Reichenbach, S., Aurbach, U., Becker, S., Bellmann, R., Bergmann, K.-C., Cornely, O. A., Engelhart, S., Fischer, G., Gabrio, T., Herr, C. E. W., Joest, M., Karagiannidis, C., Klimek, L., Köberle, M., Kolk, A., Lichtnecker, H., Lob-Corzilius, T., … Wiesmüller, G. A. (2024). AWMF mold guideline “Medical clinical diagnostics for indoor mold exposure” – Update 2023 AWMF Register No. 161/001. Allergologie Select, 8, 90-198. https://doi.org/10.5414/ALX02444E
2. Institute of Medicine, Committee on Damp Indoor Spaces and Health. (2004). Damp indoor spaces and health. https://doi.org/10.17226/11011
3. Hardin, B. D., Kelman, B. J., & Saxon, A. (2003). Adverse human health effects associated with molds in the indoor environment. Journal of Occupational and Environmental Medicine, 45(5), 470-478. https://doi.org/10.1097/00043764-200305000-00006
4. Platt, S. D., Martin, C. J., Hunt, S. M., & Lewis, C. W. (1989). Damp housing, mould growth, and symptomatic health state. BMJ (Clinical Research Ed.), 298(6689), 1673-1678. https://doi.org/10.1136/bmj.298.6689.1673
5. Sauni, R., Verbeek, J. H., Uitti, J., Jauhiainen, M., Kreiss, K., & Sigsgaard, T. (2015). Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma. Cochrane Database of Systematic Reviews, 2015(2), CD007897. https://doi.org/10.1002/14651858.CD007897.pub3
6. Kawamoto, M., & Page, E. (2015). Notes from the field: Use of unvalidated urine mycotoxin tests for the clinical diagnosis of illness — United States, 2014. MMWR. Morbidity and Mortality Weekly Report, 64(6), 157-158. https://pubmed.ncbi.nlm.nih.gov/25695323/
7. Shoemaker, R. C., & House, D. E. (2006). Sick building syndrome (SBS) and exposure to water-damaged buildings: time series study, clinical trial and mechanisms. Neurotoxicology and Teratology, 28(5), 573-588. https://doi.org/10.1016/j.ntt.2006.07.003
8. Jimenez-Barbosa, I. A., Di Lizio, S., Ahn, S. B., Heng, B., Kim, J., Watson, A. J., & Khuu, S. K. (2026). Assessment of visual contrast sensitivity in biotoxin-exposed individuals using four testing methods. Annals of Medicine, 58(1), 2646821. https://doi.org/10.1080/07853890.2026.2646821
9. Leikin, J., Holland, M. G., Kurt, T. L., McKay, C. A., & Stolbach, A. I. (American College of Medical Toxicology). (2025). ACMT position statement: Medical toxicology considerations in the diagnosis and treatment of patients with concerns about mold-related inhalation exposures. https://www.acmt.net/wp-content/uploads/2025/08/PS_250813_ACMT-Position-Statement-Mold-Related-Inhalation-Exposures.pdf
10. Liu, Y., & Wu, F. (2010). Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environmental Health Perspectives, 118(6), 818-824. https://doi.org/10.1289/ehp.0901388

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, board certified in anesthesiology, pain medicine, interventional pain management, addiction medicine and obesity medicine. Adapted from Chapter 26 of The Angry Gut by Dr. Padda and Ami Michelle Grimes. Last reviewed September 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP